Insider Trading (SEC Form 4)


Insiders are officers, directors, or significant investors. This page shows recent insider transactions for Surgical.

Transaction
Date
CompanyInsider Code
(see below)
Shares Post Shares Percent
Change
Share
Price
Tran
Value
Post
Value
Percent
Change
2018-05-28 ATRS HOBBS EAMONN P (President & CEO, Director) A 245,532 445,254 122.94
2018-01-12 XENT CARSCADDEN GWEN R. (Chief People Officer) M 10,000 13,856 259.34 12.19 121,900
2018-01-12 RVP SHAW THOMAS J (President and CEO, Director, 10% Owner) P 2,500 17,550,193 0.01 0.687 1,718 12,056,983 0.01
2018-01-12 NVCR Danziger Asaf (Chief Executive Officer, Director) S -22,895 412,968 -5.25 22.0239 -504,237 9,095,166 -5.54
2018-01-12 HART DST Capital LLC (10% Owner) P 5,000 505,450 1.00 2.16 10,800 1,091,772 0.99
2018-01-12 XENT CARSCADDEN GWEN R. (Chief People Officer) S -10,000 3,856 -72.17 34.3476 -343,476 132,444 -259.34
2018-01-11 XENT HILLEMAN JERYL L (Chief Financial Officer) M 12,835 25,767 99.25 11.12 142,725
2018-01-11 MDVX Crowne Jesse (Director) A 10,407 210,747 5.19 0.550 5,724
2018-01-11 CMD DIKER CHARLES M (Chairman, Director, 10% Owner) S -5,700 3,723,411 -0.15 107.2575 -611,368 399,363,755 -0.15
2018-01-11 RVP SHAW THOMAS J (President and CEO, Director, 10% Owner) P 3,500 17,547,693 0.02 0.685 2,398 12,020,170 0.02
2018-01-11 NVCR Danziger Asaf (Chief Executive Officer, Director) S -313,525 435,863 -41.84 22.3507 -7,007,503 9,741,843 -71.93
2018-01-11 CYTX Swissquote Bank SA (10% Owner) S -20,000 5,380,859 -0.37 0.3405 -6,810 1,832,182 -0.37
2018-01-11 CYTX Swissquote Bank SA (10% Owner) S -20,000 5,360,859 -0.37 0.3406 -6,812 1,825,909 -0.37
2018-01-11 CYTX Swissquote Bank SA (10% Owner) S -12,630 5,348,229 -0.24 0.34 -4,294 1,818,398 -0.24
2018-01-11 CYTX Swissquote Bank SA (10% Owner) S -20,000 5,328,229 -0.37 0.34 -6,800 1,811,598 -0.38
2018-01-11 HART DST Capital LLC (10% Owner) P 200 500,450 0.04 1.90 380 950,855 0.04
2018-01-11 BSX Pierce David A (SVP,Pres Urology,Pelvic Health) S -8,763 24,201 -26.58 27.7387 -243,074 671,304 -36.21
2018-01-11 XENT HILLEMAN JERYL L (Chief Financial Officer) S -12,835 12,932 -49.81 33.8052 -433,890 437,169 -99.25
2018-01-11 NVCR Kirson Eilon D. (Chief Science Officer) S -25,320 3,181 -88.84 22.0034 -557,126 69,993 -795.98
2018-01-10 NVTR Zelibor Thomas Edward (Director) M 837 5,863 16.65 9.79 8,194
2018-01-10 NVTR PARKS FRED B (Director) M 837 5,863 16.65 9.79 8,194
2018-01-10 NVTR MILLER JOSEPH A (Director) M 837 43,758 1.95 9.79 8,194
2018-01-10 NVTR JOHNSON DAVID D (Director) M 837 35,863 2.39 9.79 8,194
2018-01-10 NVTR HAWARI KENNETH G (Director) M 837 22,863 3.80 9.79 8,194
2018-01-10 NVTR Bihl Anthony P III (Director) M 837 9,302 9.89 9.79 8,194
2018-01-10 CYTX Swissquote Bank SA (10% Owner) S -15,796 5,400,859 -0.29 0.3803 -6,007 2,053,947 -0.29
2018-01-09 BSX Pierce David A (SVP,Pres Urology,Pelvic Health) M 5,152 38,116 15.63 7.4100 38,176
2018-01-09 CMD DIKER CHARLES M (Chairman, Director, 10% Owner) S -4,278 3,729,111 -0.11 107.0541 -457,977 399,216,622 -0.11
2018-01-09 NVCR GROENHUYSEN WILHELMUS CM (Chief Financial Officer) S -31,132 209,078 -12.96 21.0194 -654,376 4,394,694 -14.89
2018-01-09 CYTX Swissquote Bank SA (10% Owner) S -20,000 5,436,655 -0.37 0.3964 -7,928 2,155,090 -0.37
2018-01-09 CYTX Swissquote Bank SA (10% Owner) S -20,000 5,416,655 -0.37 0.3902 -7,804 2,113,579 -0.37
2018-01-09 CYTX Swissquote Bank SA (10% Owner) S -20,000 5,476,655 -0.36 0.38 -7,600 2,081,129 -0.37
2018-01-09 CYTX Swissquote Bank SA (10% Owner) S -20,000 5,456,655 -0.37 0.38 -7,600 2,073,529 -0.37
2018-01-09 CYTX Swissquote Bank SA (10% Owner) S -20,000 5,496,655 -0.36 0.37 -7,400 2,033,762 -0.36
2018-01-09 BSX Pierce David A (SVP,Pres Urology,Pelvic Health) S -5,152 32,964 -13.52 27.0000 -139,104 890,028 -15.63
2018-01-08 SYK COX HOWARD E JR (Director) M 7,400 532,132 1.41 67.80 501,720
2018-01-08 CTSO BLOCH KATHLEEN P. (Chief Financial Officer) M 20,000 257,638 8.42 2.90 58,000
2018-01-08 CTSO BLOCH KATHLEEN P. (Chief Financial Officer) M 12,400 270,038 4.81 4.69 58,156
2018-01-08 NVCR GROENHUYSEN WILHELMUS CM (Chief Financial Officer) A 310 240,210 0.13 15.045 4,664
2018-01-08 NVCR Longsworth Todd Christopher (General Counsel) A 166 4,998 3.44 15.045 2,497
2018-01-08 NVCR Danziger Asaf (Chief Executive Officer, Director) A 283 749,388 0.04 15.045 4,258
2018-01-08 CTSO BLOCH KATHLEEN P. (Chief Financial Officer) S -10,000 260,038 -3.70 7.15 -71,500 1,859,272 -3.85
2018-01-08 CTSO BLOCH KATHLEEN P. (Chief Financial Officer) S -12,400 247,638 -4.77 7.25 -89,900 1,795,376 -5.01
2018-01-08 CTSO BLOCH KATHLEEN P. (Chief Financial Officer) S -10,000 237,638 -4.04 7.50 -75,000 1,782,285 -4.21
2018-01-08 ENTL Williamson Thomas P. (VP, Commercial Operations) S -1,481 44,986 -3.19 24.12 -35,722 1,085,062 -3.29
2018-01-07 NVTR Kaula Norbert (EVP, Research & Development) M 499 3,769 15.26 7.86 3,922
2018-01-07 NVTR Hanchin Joseph Paul (President) M 4,273 29,933 16.65 7.86 33,586
2018-01-07 NVTR DREES SCOTT F (CEO, Director) M 16,024 157,248 11.35 7.86 125,949
2018-01-07 NVTR BERGER WALTER Z (CFO) M 8,012 56,124 16.65 7.86 62,974
2018-01-06 ATRC Noznesky Justin J (SVP, Mktg & Business Develop) F -3,182 128,997 -2.41 17.99 -57,244
A
Grant, award, or other acquisition of securities from the company (such as an option)
K
Equity swaps and similar hedging transactions
P
Purchase of securities on an exchange or from another person
S
Sale of securities on an exchange or to another person
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
M
Exercise or conversion of derivative security received from the company (such as an option)
G
Gift of securities by or to the insider
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)